<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>From 218 patients aged 15 to 72 years suffering from inflammatory <z:e sem="disease" ids="C0009450" disease_type="Disease or Syndrome" abbrv="">infectious diseases</z:e> of the central <z:mp ids='MP_0008912'>nervous</z:mp> system, 162 patients were treated with high doses of immunoglobulins (Ig) </plain></SENT>
<SENT sid="1" pm="."><plain>The therapeutic results were compared with those of the 56 patients without an additive therapy, separately for <z:mp ids='MP_0001794'>bacterial</z:mp> and <z:mp ids='MP_0001799'>viral</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>If we compare recoveries and <z:hpo ids='HP_0011420'>deaths</z:hpo> or survivals but defective recoveries, the chi-square test reveals that treatment with Ig at the 0.1 percent level is superior to treatment without Ig in a highly significant manner in favor of the use of Ig </plain></SENT>
<SENT sid="3" pm="."><plain>Using other criteria, such as the duration of <z:hpo ids='HP_0001945'>fever</z:hpo> and the length of hospital confinement, calculations using Student's t-test also show significant results in favor of Ig </plain></SENT>
<SENT sid="4" pm="."><plain>Early beginning of therapy with high doses of Ig given intravenously, or if necessary intrathecally, proved to be of great therapeutic value in lowering the number of fatalities and defective recoveries </plain></SENT>
</text></document>